A NIDRR-funded TBI Model Systems Collaboratives grant study was published today in the New England Journal of Medicine. The placebo-controlled trial was led by Drs. Joseph Giacino and John Whyte of JFK Johnson Rehabilitation Institute and Moss Rehabilitation Research Institute, respectively. Study findings show that daily doses of a Parkinson's drug significantly improved function in patients thought to be beyond the reach of treatment. If the study can be replicated, promise exists for a standard treatment to help injuries that are generally unpredictable.